A NEW study on mutation testing
in lung cancer highlights the
advantages of multi-gene testing to
provide patients with effective
personalised medicine, according to
The Royal College of Pathologists of
Australasia (RCPA).
The study, conducted by RCPA
spokesperson Professor Sandra
O’Toole, looked in detail, at early
stage lung adenocarcinoma
before it has spread to lymph
nodes or the rest of the body, and
found that early cancer is often
different to advanced cancer in its
genetic makeup and should be
tested and treated accordingly.
“What we do with mutation
testing is look for the specific gene
or genes that the cancer relies on
and use targeted treatments to
shut them down,” Professor
O’Toole said.The above article was sent to subscribers in Pharmacy Daily's issue from 26 Feb 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 26 Feb 13
THE role and significance of community pharmacy in regional areas was a key focus of discussion for the Nationals leader David Littleproud during last week’s visit to Orana Mall Pharmacy as part of a regional tour.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.